Author :   Оmelchenko L.I.

TO THE QUESTION OF THE POSSIBILITY AND ACCEPTABILITY OF USING OFF-LABEL DRUGS IN PEDIATRIC RHEUMATOLOGY ACCORDING TO EXPERIENCE WITH RITUXIMAB IN CHILDREN WITH SYSTEMIC CONNECTIVE TISSUE DISEASES THAT ARE RESISTANT TO THERAPY
Authors: Oshlianska O.A. Оmelchenko L.I. №81 (3) 2020 / Review: 20

Succession and effectiveness of the treatment of juvenile idiopathic arthritis: directions of personalized therapy
Authors: Kovalenko V. Оmelchenko L.I. Yaremenko O.B. Marushko T.V.... №64 (2) 2016 / Review: 13

Substantiation report concerning retention of diagnosis «Juvenile rheumatoid arthritis» status in adult patients with a disease onset in childhood and adolescence
Authors: Kovalenko V. Shuba N.M. Yaremenko O.B. Оmelchenko L.I.... №63 (1) 2016 / Review: 12

Prediction of risks of refractory disease course in Juvenile Rheumatoid Arthritis based on disease subtype, activity, number of unfavourable factors and cytokine markers of unfavourable prognosis
Authors: Boyko Y.Y. Оmelchenko L.I. Chernyshov V.P. №58 (4) 2014 / Review: 11